Cargando…
Inhalation delivery of dexamethasone with iSEND nanoparticles attenuates the COVID-19 cytokine storm in mice and nonhuman primates
Dexamethasone (DEX) is the first drug to show life-saving efficacy in patients with severe coronavirus disease 2019 (COVID-19), while DEX is associated with serious adverse effects. Here, we report an inhaled, Self-immunoregulatory, Extracellular Nanovesicle-based Delivery (iSEND) system by engineer...
Autores principales: | Meng, Qian-Fang, Tai, Wanbo, Tian, Mingyao, Zhuang, Xinyu, Pan, Yuanwei, Lai, Jialin, Xu, Yangtao, Xu, Zhiqiang, Li, Min, Zhao, Guangyu, Yu, Guang-Tao, Yu, Guocan, Chen, Rongchang, Jin, Ningyi, Li, Xiao, Cheng, Gong, Chen, Xiaoyuan, Rao, Lang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266725/ https://www.ncbi.nlm.nih.gov/pubmed/37315135 http://dx.doi.org/10.1126/sciadv.adg3277 |
Ejemplares similares
-
Association of the prognostic model iSEND with PD-1/L1 monotherapy outcome in non-small-cell lung cancer
por: Park, Wungki, et al.
Publicado: (2019) -
LIPI及iSEND免疫评分在晚期非小细胞肺癌免疫治疗中的预测价值分析
Publicado: (2022) -
FasL microgels induce immune acceptance of islet allografts in nonhuman primates
por: Lei, Ji, et al.
Publicado: (2022) -
Inducible nonhuman primate models of retinal degeneration for testing end-stage therapies
por: Ail, Divya, et al.
Publicado: (2023) -
Peptide-guided lipid nanoparticles deliver mRNA to the neural retina of rodents and nonhuman primates
por: Herrera-Barrera, Marco, et al.
Publicado: (2023)